Fig. 1From: Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case reportMRI during the early phase and at the peak of post-natalizumab exacerbation. The upper panel shows Fluid inversion recovery (FLAIR; a, b and c) and T2 (d) from June 2015. The middle panel shows examples of new and enlarging lesions on corresponding FLAIR (e, f and g) and T2 (h) sections at March 2016. The lower panel (i, j and k) shows examples of gadolinium enhancement on T1 images at March 2016Back to article page